{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,26]],"date-time":"2026-06-26T04:57:54Z","timestamp":1782449874322,"version":"3.54.5"},"reference-count":49,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2014,1,1]],"date-time":"2014-01-01T00:00:00Z","timestamp":1388534400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Neuroscience"],"published-print":{"date-parts":[[2014,1]]},"DOI":"10.1016\/j.neuroscience.2013.09.061","type":"journal-article","created":{"date-parts":[[2013,10,12]],"date-time":"2013-10-12T07:01:33Z","timestamp":1381561293000},"page":"72-82","source":"Crossref","is-referenced-by-count":45,"special_numbering":"C","title":["In vivo modulation of polo-like kinases supports a key role for PLK2 in Ser129 \u03b1-synuclein phosphorylation in mouse brain"],"prefix":"10.1016","volume":"256","author":[{"given":"M.","family":"Bergeron","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.","family":"Motter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.","family":"Tanaka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D.","family":"Fauss","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Babcock","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.-s.","family":"Chiou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Nelson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F.","family":"San Pablo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.P.","family":"Anderson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.neuroscience.2013.09.061_b0005","doi-asserted-by":"crossref","first-page":"29739","DOI":"10.1074\/jbc.M600933200","article-title":"Phosphorylation of Ser-129 is the dominant pathological modification of alpha-synuclein in familial and sporadic Lewy body disease","volume":"281","author":"Anderson","year":"2006","journal-title":"J Biol Chem"},{"key":"10.1016\/j.neuroscience.2013.09.061_b0010","doi-asserted-by":"crossref","first-page":"9227","DOI":"10.1523\/JNEUROSCI.0341-06.2006","article-title":"The role of G-protein-coupled receptor kinase 5 in pathogenesis of sporadic Parkinson\u2019s disease","volume":"26","author":"Arawaka","year":"2006","journal-title":"J Neurosci"},{"key":"10.1016\/j.neuroscience.2013.09.061_b0015","doi-asserted-by":"crossref","first-page":"1295","DOI":"10.1002\/cmdc.201300166","article-title":"Selective and brain-permeable Polo-Like Kinase-2 (Plk-2) inhibitors that reduce \u03b1-synuclein phosphorylation in rat brain","volume":"8","author":"Aubele","year":"2013","journal-title":"ChemMedChem"},{"key":"10.1016\/j.neuroscience.2013.09.061_b0020","doi-asserted-by":"crossref","first-page":"2743","DOI":"10.1016\/j.bmcl.2013.02.065","article-title":"Design and synthesis of highly selective, orally active Polo-like kinase-2 (Plk-2) inhibitors","volume":"23","author":"Bowers","year":"2013","journal-title":"Bioorg Med Chem Lett"},{"issue":"Suppl. 3","key":"10.1016\/j.neuroscience.2013.09.061_b0025","doi-asserted-by":"crossref","first-page":"III\/1","DOI":"10.1007\/s00415-002-1301-4","article-title":"Staging of the intracerebral inclusion body pathology associated with idiopathic Parkinson\u2019s disease (preclinical and clinical stages)","volume":"249","author":"Braak","year":"2002","journal-title":"J Neurol"},{"key":"10.1016\/j.neuroscience.2013.09.061_b0030","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1515\/revneuro-2011-0067","article-title":"\u03b1-Synuclein phosphorylation as a therapeutic target in Parkinson\u2019s disease","volume":"23","author":"Braithwaite","year":"2012","journal-title":"Rev Neurosci"},{"key":"10.1016\/j.neuroscience.2013.09.061_b0035","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1016\/S0140-6736(04)17103-1","article-title":"Alpha-synuclein locus duplication as a cause of familial Parkinson\u2019s disease","volume":"364","author":"Chartier-Harlin","year":"2004","journal-title":"Lancet"},{"key":"10.1016\/j.neuroscience.2013.09.061_b0040","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1111\/j.1471-4159.2009.06191.x","article-title":"Relationship between alpha synuclein phosphorylation, proteasomal inhibition and cell death: relevance to Parkinson\u2019s disease pathogenesis","volume":"110","author":"Chau","year":"2009","journal-title":"J Neurochem"},{"key":"10.1016\/j.neuroscience.2013.09.061_b0045","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1038\/nn1443","article-title":"Alpha-synuclein phosphorylation controls neurotoxicity and inclusion formation in a Drosophila model of Parkinson disease","volume":"8","author":"Chen","year":"2005","journal-title":"Nat Neurosci"},{"key":"10.1016\/j.neuroscience.2013.09.061_b0050","doi-asserted-by":"crossref","first-page":"2255","DOI":"10.4161\/cc.10.14.16494","article-title":"From Plk1 to Plk5: functional evolution of polo-like kinases","volume":"10","author":"de C\u00e1rcer","year":"2011","journal-title":"Cell Cycle"},{"key":"10.1016\/j.neuroscience.2013.09.061_b0055","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1007\/s00401-012-1004-6","article-title":"Protein degradation pathways in Parkinson\u2019s disease: curse or blessing","volume":"124","author":"Ebrahimi-Fakhari","year":"2012","journal-title":"Acta Neuropathol"},{"key":"10.1016\/j.neuroscience.2013.09.061_b0060","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/S0006-8993(01)03046-3","article-title":"Distribution of G-protein-coupled receptor kinase (GRK) isoforms 2, 3, 5 and 6 mRNA in the rat brain","volume":"95","author":"Erdtmann-Vourliotis","year":"2001","journal-title":"Mol Brain Res"},{"key":"10.1016\/j.neuroscience.2013.09.061_b0065","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/j.jneumeth.2013.03.012","article-title":"Development of an enzyme-linked immunosorbant assay to measure tyrosine hydroxylase protein in brain tissue from Parkinson\u2019s disease models","volume":"215","author":"Fauss","year":"2013","journal-title":"J Neurosci Methods"},{"key":"10.1016\/j.neuroscience.2013.09.061_b0070","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.taap.2013.02.012","article-title":"Pharmacological inhibition of Polo Like Kinase 2 (PLK2) does not cause chromosomal damage or result in the formation of micronuclei","volume":"269","author":"Fitzgerald","year":"2013","journal-title":"Toxicol Appl Pharmacol"},{"key":"10.1016\/j.neuroscience.2013.09.061_b0075","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1038\/ncb748","article-title":"Alpha-Synuclein is phosphorylated in synucleinopathy lesions","volume":"4","author":"Fujiwara","year":"2002","journal-title":"Nat Cell Biol"},{"key":"10.1016\/j.neuroscience.2013.09.061_b0080","doi-asserted-by":"crossref","first-page":"2598","DOI":"10.1074\/jbc.C800206200","article-title":"Polo-like kinase 2 (PLK2) phosphorylates alpha-synuclein at serine 129 in central nervous system","volume":"284","author":"Inglis","year":"2009","journal-title":"J Biol Chem"},{"key":"10.1016\/j.neuroscience.2013.09.061_b0085","doi-asserted-by":"crossref","first-page":"4711","DOI":"10.1016\/j.febslet.2007.08.067","article-title":"Casein kinase 2 is the major enzyme in brain that phosphorylates Ser129 of human alpha-synuclein: implication for alpha-synucleinopathies","volume":"581","author":"Ishii","year":"2007","journal-title":"FEBS Lett"},{"key":"10.1016\/j.neuroscience.2013.09.061_b0090","doi-asserted-by":"crossref","first-page":"5528","DOI":"10.1093\/emboj\/18.20.5528","article-title":"The polo-like protein kinases Fnk and Snk associate with a Ca(2+)- and integrin-binding protein and are regulated dynamically with synaptic plasticity","volume":"18","author":"Kauselmann","year":"1999","journal-title":"EMBO J"},{"key":"10.1016\/j.neuroscience.2013.09.061_b0095","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.mcn.2011.09.002","article-title":"Parkinson-related parkin reduces \u03b1-Synuclein phosphorylation in a gene transfer model","volume":"49","author":"Khandelwal","year":"2012","journal-title":"Mol Cell Neurosci"},{"key":"10.1016\/j.neuroscience.2013.09.061_b0100","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1038\/sj.onc.1208280","article-title":"Structure and function of Polo-like kinases","volume":"24","author":"Lowery","year":"2005","journal-title":"Oncogene"},{"key":"10.1016\/j.neuroscience.2013.09.061_b0105","doi-asserted-by":"crossref","first-page":"6936","DOI":"10.1128\/MCB.23.19.6936-6943.2003","article-title":"Role of Plk2 (Snk) in mouse development and cell proliferation","volume":"23","author":"Ma","year":"2003","journal-title":"Mol Cell Biol"},{"key":"10.1016\/j.neuroscience.2013.09.061_b0110","doi-asserted-by":"crossref","first-page":"40732","DOI":"10.1074\/jbc.M110.141952","article-title":"Phosphorylated alpha-synuclein at Ser-129 is targeted to the proteasome pathway in a ubiquitin-independent manner","volume":"285","author":"Machiya","year":"2010","journal-title":"J Biol Chem"},{"key":"10.1016\/j.neuroscience.2013.09.061_b0115","doi-asserted-by":"crossref","first-page":"e315","DOI":"10.1038\/cddis.2012.50","article-title":"Increased \u03b1-synuclein phosphorylation and nitration in the aging primate substantia nigra","volume":"3","author":"McCormack","year":"2012","journal-title":"Cell Death Dis"},{"key":"10.1016\/j.neuroscience.2013.09.061_b0120","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1097\/NEN.0b013e318180f0bd","article-title":"Pathologic modifications of alpha-synuclein in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-treated squirrel monkeys","volume":"67","author":"McCormack","year":"2008","journal-title":"J Neuropathol Exp Neurol"},{"key":"10.1016\/j.neuroscience.2013.09.061_b0125","doi-asserted-by":"crossref","first-page":"2807","DOI":"10.1074\/jbc.M109.081950","article-title":"Phosphorylation of synucleins by members of the Polo-like kinase family","volume":"285","author":"Mbefo","year":"2010","journal-title":"J Biol Chem"},{"key":"10.1016\/j.neuroscience.2013.09.061_b0130","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1016\/S0006-8993(02)02643-4","article-title":"Immunohistochemical comparison of alpha- and beta-synuclein in adult rat central nervous system","volume":"941","author":"Mori","year":"2002","journal-title":"Brain Res"},{"key":"10.1016\/j.neuroscience.2013.09.061_b0135","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1074\/jbc.275.1.390","article-title":"Constitutive phosphorylation of the Parkinson\u2019s disease associated alpha-synuclein","volume":"275","author":"Okochi","year":"2000","journal-title":"J Biol Chem"},{"key":"10.1016\/j.neuroscience.2013.09.061_b0140","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/S0079-6123(10)83007-9","article-title":"Role of post-translational modifications in modulating the structure, function and toxicity of alpha-synuclein: implications for Parkinson\u2019s disease pathogenesis and therapies","volume":"183","author":"Oueslati","year":"2010","journal-title":"Prog Brain Res"},{"key":"10.1016\/j.neuroscience.2013.09.061_b0250","doi-asserted-by":"crossref","first-page":"1368","DOI":"10.1126\/science.1082475","article-title":"Targeted protein degradation and synapse remodeling by an inducible protein kinase","volume":"302","author":"Pak","year":"2003","journal-title":"Science"},{"key":"10.1016\/j.neuroscience.2013.09.061_b0145","series-title":"The mouse brain in stereotaxic coordinates","author":"Paxinos","year":"2001"},{"key":"10.1016\/j.neuroscience.2013.09.061_b0150","doi-asserted-by":"crossref","first-page":"26515","DOI":"10.1074\/jbc.M003542200","article-title":"Synucleins are a novel class of substrates for G protein-coupled receptor kinases","volume":"275","author":"Pronin","year":"2000","journal-title":"J Biol Chem"},{"key":"10.1016\/j.neuroscience.2013.09.061_b0155","doi-asserted-by":"crossref","first-page":"e24834","DOI":"10.1371\/journal.pone.0024834","article-title":"Neuropathology in mice expressing mouse alpha-synuclein","volume":"6","author":"Rieker","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.neuroscience.2013.09.061_b0160","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/j.neuroscience.2011.11.003","article-title":"Identification and functional characterization of polo-like kinase 2 autoregulatory sites","volume":"202","author":"Rozeboom","year":"2012","journal-title":"Neuroscience"},{"key":"10.1016\/j.neuroscience.2013.09.061_b0165","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.jns.2007.08.027","article-title":"Localization of CKII beta subunits in Lewy bodies of Parkinson\u2019s disease","volume":"266","author":"Ryu","year":"2008","journal-title":"J Neurol Sci"},{"key":"10.1016\/j.neuroscience.2013.09.061_b0170","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1093\/jnen\/62.6.644","article-title":"Accumulation of phosphorylated alpha-synuclein in aging human brain","volume":"62","author":"Saito","year":"2003","journal-title":"J Neuropathol Exp Neurol"},{"key":"10.1016\/j.neuroscience.2013.09.061_b0175","first-page":"1","article-title":"The role of Ser129 phosphorylation of \u03b1-synuclein in neurodegeneration of Parkinson\u2019s disease: a review of in vivo models","volume":"9","author":"Sato","year":"2013","journal-title":"Rev Neurosci"},{"key":"10.1016\/j.neuroscience.2013.09.061_b0185","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1016\/j.neuroscience.2009.03.002","article-title":"Nuclear and neuritic distribution of serine-129 phosphorylated alpha-synuclein in transgenic mice","volume":"160","author":"Schell","year":"2009","journal-title":"Neuroscience"},{"issue":"629","key":"10.1016\/j.neuroscience.2013.09.061_b0190","first-page":"20","article-title":"Proteosomal inhibition increases phospho-synuclein levels","volume":"35","author":"Schoebel","year":"2009","journal-title":"Soc Neurosci Abstr"},{"key":"10.1016\/j.neuroscience.2013.09.061_b0195","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1038\/sj.onc.1208277","article-title":"Polo-like kinases in the nervous system","volume":"24","author":"Seeburg","year":"2005","journal-title":"Oncogene"},{"key":"10.1016\/j.neuroscience.2013.09.061_b0200","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1126\/science.1090278","article-title":"Alpha-Synuclein locus triplication causes Parkinson\u2019s disease","volume":"302","author":"Singleton","year":"2003","journal-title":"Science"},{"key":"10.1016\/j.neuroscience.2013.09.061_b0205","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1016\/j.cub.2006.12.037","article-title":"BI 2536, a potent and selective inhibitor of polo-like kinase 1, inhibits tumor growth in vivo","volume":"17","author":"Steegmaier","year":"2007","journal-title":"Curr Biol"},{"key":"10.1016\/j.neuroscience.2013.09.061_b0210","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.1016\/j.bbamcr.2008.02.019","article-title":"Polo-box domains confer target specificity to the Polo-like kinase family","volume":"1783","author":"van de Weerdt","year":"2008","journal-title":"Biochim Biophys Acta"},{"key":"10.1016\/j.neuroscience.2013.09.061_b0215","doi-asserted-by":"crossref","first-page":"35863","DOI":"10.1074\/jbc.M111.253450","article-title":"Effect of Ser-129 phosphorylation on interaction of \u03b1-synuclein with synaptic and cellular membranes","volume":"286","author":"Visanji","year":"2011","journal-title":"J Biol Chem"},{"key":"10.1016\/j.neuroscience.2013.09.061_b0220","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.jchemneu.2010.12.003","article-title":"Different sub-cellular localization of alpha-synuclein in the C57BL\/6J mouse\u2019s central nervous system by two novel monoclonal antibodies","volume":"41","author":"Vivacqua","year":"2011","journal-title":"J Chem Neuroanat"},{"key":"10.1016\/j.neuroscience.2013.09.061_b0225","doi-asserted-by":"crossref","first-page":"1819","DOI":"10.1002\/jnr.21310","article-title":"Accumulation of phosphorylated alpha-synuclein in dopaminergic neurons of transgenic mice that express human alpha-synuclein","volume":"85","author":"Wakamatsu","year":"2007","journal-title":"J Neurosci Res"},{"key":"10.1016\/j.neuroscience.2013.09.061_b0230","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1097\/NEN.0b013e3186fc995","article-title":"Specificity and regulation of casein kinase-mediated phosphorylation of alpha-synuclein","volume":"67","author":"Waxman","year":"2008","journal-title":"J Neuropathol Exp Neurol"},{"key":"10.1016\/j.neuroscience.2013.09.061_b0235","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1016\/j.neuroscience.2006.12.028","article-title":"Extensive nuclear localization of alpha-synuclein in normal rat brain neurons revealed by a novel monoclonal antibody","volume":"145","author":"Yu","year":"2007","journal-title":"Neuroscience"},{"key":"10.1016\/j.neuroscience.2013.09.061_b0240","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1002\/ana.10795","article-title":"The new mutation, E46K, of alpha-synuclein causes Parkinson and Lewy body dementia","volume":"55","author":"Zarranz","year":"2004","journal-title":"Ann Neurol"},{"key":"10.1016\/j.neuroscience.2013.09.061_b0245","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1007\/s00401-011-0815-1","article-title":"Changes in the solubility and phosphorylation of \u03b1-synuclein over the course of Parkinson\u2019s disease","volume":"121","author":"Zhou","year":"2011","journal-title":"Acta Neuropathol"}],"container-title":["Neuroscience"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0306452213008403?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0306452213008403?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,7,30]],"date-time":"2019-07-30T19:13:22Z","timestamp":1564514002000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0306452213008403"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,1]]},"references-count":49,"alternative-id":["S0306452213008403"],"URL":"https:\/\/doi.org\/10.1016\/j.neuroscience.2013.09.061","relation":{},"ISSN":["0306-4522"],"issn-type":[{"value":"0306-4522","type":"print"}],"subject":[],"published":{"date-parts":[[2014,1]]}}}